DELANO REGIONAL MED. CTR. — History
CCN 050608 | 3-year financial timeline | COVID resilience: 30/100
🛡️ Public data only — no PHI permitted on this instance.
$79M
Latest Revenue (FY2022)
-2.1%
Revenue CAGR (3yr)
-46.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $83M | $99M | $79M | -20.0% | -2.1% |
| Operating Expenses | $86M | $102M | $116M | +13.7% | +15.8% |
| Operating Margin | -4.6% | -2.9% | -46.4% | -1474.2% | +0.0% |
| Net Income | $-4M | $-3M | $-37M | -1159.1% | +0.0% |
| Licensed Beds | 105 | 105 | 105 | +0.0% | +0.0% |
| Total Patient Days | 8,248 | 9,670 | 8,320 | -14.0% | +0.4% |
| Medicare Day % | 24% | 25% | 24% | -3.5% | -0.1% |
| Medicaid Day % | 13% | 13% | 13% | -0.5% | +2.4% |
COVID Impact & Recovery
Resilience Score: 30/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -4.2% ($83M → $79M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-2.1%
This Hospital
+7.6%
State Avg
Latest Margin
-46.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $77M | -67.3% |
| FY2024 (proj) | $76M | -88.2% |
| FY2025 (proj) | $74M | -109.1% |